Brown Brothers Harriman & Co’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Brown Brothers Harriman & Co’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-72	Closed	-$16	–	1230
2021 Q1	$16	Sell	72 -1,625	-96%	-$305K	﹤0.01%	806
2020 Q4	$196K	Hold	1,697	–	–	﹤0.01%	442
2020 Q3	$165K	Hold	1,697	–	–	﹤0.01%	420
2020 Q2	$208K	Hold	1,697	–	–	﹤0.01%	371
2020 Q1	$149K	Sell	1,697 -29	-2%	-$3.07K	﹤0.01%	393
2019 Q4	$180K	Sell	1,726 -45	-3%	-$5.05K	﹤0.01%	486
2019 Q3	$204K	Hold	1,771	–	–	﹤0.01%	428
2019 Q2	$305K	Hold	1,771	–	–	﹤0.01%	334
2019 Q1	$299K	Buy	1,771 +146	+9%	+$21.7K	﹤0.01%	326
2018 Q4	$158K	Hold	1,625	–	–	﹤0.01%	381
2018 Q3	$281K	Buy	+1,625	New	+$234K	﹤0.01%	310
2018 Q1	–	Sell	-553	Closed	-$73K	–	1215
2017 Q4	$73K	Buy	+553	New	+$65K	﹤0.01%	477

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $983M AUM 34.23% 1-Year Est. Return

Brown Brothers Harriman & Co's GWPH Position: Q2 2021 in Review

Brown Brothers Harriman & Co sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 72 shares — an estimated $16 sold.

Brown Brothers Harriman & Co first reported a position in GWPH in Q4 2017 and held it in 12 quarters. The position peaked at $305K in Q2 2019. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Brown Brothers Harriman & Co reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Brown Brothers Harriman & Co sold 72 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $16.
Brown Brothers Harriman & Co first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2017 and held it in 12 quarters.
Brown Brothers Harriman & Co's GW Pharmaceuticals Plc American Depositary Shares position peaked at $305K in Q2 2019.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Brown Brothers Harriman & Co's 13F filing for Q2 2021, filed 13 Aug 2021.